ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,297, issued on March 17, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Anti-IL-23p19 antibody formulations" was invented by Patrick Garidel (Biberach an der Riss, Germany) and Torsten Schultz-Fademrecht (Aepfingen, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure inter alia provides a liquid pharmaceutical formulation comprising a) 150 mg/ml of an anti-IL-23p19 antibody, wherein the antibody comprises a light chain amino acid sequence according to SEQ ID NO: 1 and a heavy chain amino acid sequence according to SEQ ID NO: 2; b) a polyol; and c) a surfactant. The disclosed high co...